Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00012636 · ClinicalTrials.gov registry record · NA
Guidelines for Drug Therapy of Hypertension: Closing the Loop
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT00012636 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 36 participants.
The verdict
NCT00012636, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
Hypertension is a major risk factor for heart disease and stroke. Evidence-based guidelines support the use of specific drugs for patients with specific comorbidities to maximize the decrease in cardiovascular risk; yet, many physicians do not follow these guidelines in choosing drug therapy.
Interventions
- PROCEDURE Computer generated statements about guideline concordance of drug therapy deliver to clinicians
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Est. Completion | 2000-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00012636
The ClinicalTrials.gov registry entry for NCT00012636 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Computer generated statements about guideline concordance of drug therapy deliver to clinicians is the first listed.
NCT00012636 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00012636 about?
NCT00012636 is a clinical study titled "Guidelines for Drug Therapy of Hypertension: Closing the Loop". Hypertension is a major risk factor for heart disease and stroke. Evidence-based guidelines support the use of specific drugs for patients with specific comorbidities to maximize the decrease in cardiovascular risk; yet, many physicians do not follow these guidelines in choosing drug therapy.
What is the current status of trial NCT00012636?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. Estimated completion is 2000-09.
What interventions are being tested in trial NCT00012636?
The interventions under investigation include: Computer generated statements about guideline concordance of drug therapy deliver to clinicians (PROCEDURE).
Who is sponsoring clinical trial NCT00012636?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.